FDA Drug Application (205057) for TAPENTADOL by ROXANE

Back to FDA Applications sponsored by ROXANE

Application Number205057
Product Number001
FormTABLET;ORAL
Dosage50MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAPENTADOL
Active IngredientTAPENTADOL



Back to FDA Applications sponsored by ROXANE